These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 9032579

  • 21. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J, Lauwers MH, Vanlersberghe C, Camu F.
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract] [Full Text] [Related]

  • 22. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G, Panzetta G.
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [Abstract] [Full Text] [Related]

  • 23. Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia.
    Linder JD, Mönkemüller KE, Davis JV, Wilcox CM.
    South Med J; 2000 Sep; 93(9):930-2. PubMed ID: 11005360
    [Abstract] [Full Text] [Related]

  • 24. COX-2 inhibitors and Celebrex: safe or suspect?
    Health News; 1999 Jun 01; 5(7):4. PubMed ID: 10932776
    [No Abstract] [Full Text] [Related]

  • 25. Mechanism of action of antiinflammatory drugs.
    Vane JR, Botting RM.
    Int J Tissue React; 1998 Jun 01; 20(1):3-15. PubMed ID: 9561441
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ, Schwartz BD.
    Mediators Inflamm; 2002 Oct 01; 11(5):275-86. PubMed ID: 12467519
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS.
    Nat Med; 1999 Dec 01; 5(12):1418-23. PubMed ID: 10581086
    [Abstract] [Full Text] [Related]

  • 28. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G, Giovanni P.
    J Nephrol; 2002 Dec 01; 15(5):480-8. PubMed ID: 12455713
    [Abstract] [Full Text] [Related]

  • 29. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H, Izon DJ, Loftin C, Spain LM.
    Cell Immunol; 2001 Dec 15; 214(2):184-93. PubMed ID: 12088417
    [Abstract] [Full Text] [Related]

  • 30. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May 15; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 31. The multisystem adverse effects of NSAID therapy.
    James DS.
    J Am Osteopath Assoc; 1999 Nov 15; 99(11 Suppl):S1-7. PubMed ID: 10643174
    [Abstract] [Full Text] [Related]

  • 32. COX-2 inhibitors. What is their place?
    McGettigan P.
    Aust Fam Physician; 2000 Sep 15; 29(9):847-52. PubMed ID: 11008387
    [Abstract] [Full Text] [Related]

  • 33. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 15; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 34. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 35. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
    Lamarque D.
    Bull Cancer; 2004 May 01; 91 Spec No():S117-24. PubMed ID: 15239340
    [Abstract] [Full Text] [Related]

  • 36. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A, Ottani A, Sandrini M.
    Pharmacol Res; 2001 Dec 01; 44(6):437-50. PubMed ID: 11735348
    [Abstract] [Full Text] [Related]

  • 37. The unmet anti-inflammatory needs in orthopedics.
    Trippel SB.
    Am J Orthop (Belle Mead NJ); 1999 Mar 01; 28(3 Suppl):3-7. PubMed ID: 10193996
    [Abstract] [Full Text] [Related]

  • 38. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC.
    Nature; 1999 Mar 01; 384(6610):644-8. PubMed ID: 8967954
    [Abstract] [Full Text] [Related]

  • 39. NSAIDs, Helicobacter pylori, and Pandora's Box.
    Graham DY.
    N Engl J Med; 2002 Dec 26; 347(26):2162-4. PubMed ID: 12501230
    [No Abstract] [Full Text] [Related]

  • 40. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov 26; 27(1):1-3. PubMed ID: 11724695
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.